DPT and type 2 diabetes mellitus: Therefore, we first analysed whether obesity and its associated pathologies T2D and nonalcoholic fatty liver disease (NAFLD) influence the expression levels of DPT. In addition, the regulation of DPT by different inflammatory mediators was further explored in human visceral adipocytes.